NASDAQ · Medical - Devices

HYPR (HYPR) Stock

$0.94 +0.99% NASDAQ: HYPR Healthcare

Valuation

MetricValue
Price$0.94
Market Cap$78.94M
P/E Ratio-3.44
P/B Ratio3.00
P/S Ratio8.06
EPS (TTM)$-0.43
52-Week High$2.22
52-Week Low$0.66
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-87.80%
ROA-65.45%
ROCE-90.24%
Gross Margin-264.29%
Operating Margin-264.29%
Net Margin-2.27%
Debt/Equity0.00
Current Ratio4.25

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.0M$7.0M$11.0M$13.0M$14.0M
Operating Profit$-65.0M$-74.0M$-48.0M$-43.0M$-37.0M
Net Profit$-65.0M$-73.0M$-44.0M$-41.0M$-36.0M
EPS$-0.92$-1.04$-0.62$-0.56$-0.43
Op Margin-4336.1%-1084.2%-436.1%-335.3%-273.4%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$202.0M$134.0M$94.0M$59.0M$55.0M
Total Liabilities$16.0M$10.0M$10.0M$10.0M$14.0M
Cash$188.0M$118.0M$75.0M$38.0M$35.0M
Borrowings$0$0$0$0$0

Latest News

Hyperfine launches next-generation Swoop MRI system in Europe Hospital Management · Jul 2, 2026 Hyperfine Announces European Launch of Next-Generation Swoop® System Business Wire · Jul 1, 2026 Hyperfine Forms Global Neurosurgery Advisory Council to Support Expansion of Portable MRI in Neurosurgical Care Business Wire · Jun 22, 2026 Hyperfine Swoop® System Scan Volume in the United States Hits Record Milestones Across Multiple Sites of Care Business Wire · Jun 18, 2026 Hyperfine, Forward Industries, Sharplink Set for Russell Index Inclusion MT Newswires · May 26, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-47.0M$-72.0M$-42.0M$-39.0M$-28.0M
Investing Cash Flow$-5.0M$-1.0M$-2.0M$-1.0M$-2.0M
Financing Cash Flow$146.0M$0$0$0$0
Net Cash Flow$127.0M$-73.0M$-42.0M$-38.0M$-2.0M
Free Cash Flow$-50.0M$-73.0M$-43.0M$-39.0M$-29.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-23.20%
Quick Ratio4.90
Interest Coverage—
Return 1Y29.19%
Return 3Y-55.36%
Return 5Y-89.48%

Ownership

Insiders Held4.81%
Institutions Held14.67%
Institutions Float Held15.42%
Institutional HolderSharesReport Date
Vanguard Capital Management LLC3,453,1632026-03-31
Fosun International Ltd1,742,0202026-03-31
Catalio Capital Management, LP 1,320,0412026-03-31
Sio Capital Management, LLC1,000,0002026-03-31
Geode Capital Management, LLC955,2602026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CNTB $2.07 -1.67% -2.31 $130.02M 0.00%
EDAPEdap Tms S.a. $4.76 -0.52% -6.63 $178.23M 0.00%
FONR $19.09 +0.00% 15.33 $117.76M 0.00%
IMA $5.69 +1.07% -1.49 $64.18M 0.00%
LUNG $1.22 +4.27% -1.23 $51.53M 0.00%

About HYPR

HYPR is led by CEO Maria Degois-Sainz, employs 111 people, headquartered in US, publicly traded since 2021.

HYPR stock trades at $0.94 with a market capitalization of $78.94M. The stock is valued at a price-to-earnings (P/E) ratio of -3.44, price-to-book of 3.00, price-to-sales of 8.06. Over the past 52 weeks the stock has ranged between $0.66 and $2.22, and currently trades 57.7% below its 52-week high.

On profitability, HYPR generates a return on equity (ROE) of -87.80%, return on capital employed of -90.24%, an operating margin of -264.29%, a net profit margin of -2.27%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides